Friday, May 1, 2026

Tim Cook on Edge: Will Glass Fiber Shortage Delay the iPhone 17?

Apple CEO Tim Cook is uneasy over supply chain issues affecting iPhone 17 production due to a shortage of key materials.

Pyongyang Approves New Laws to Bolster Farms and Safeguard Consumers

North Korea has enacted two new laws to enhance farm operations and consumer rights, aiming for improved quality of life.

From Russia with Loyalty: Youth Delegation Strengthens North Korea Bonds

North Korea criticizes U.S. arms trade policies while highlighting domestic construction and revolutionary spirit among youth.

Tag: loss

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Significant Weight Loss Substantially Increases Mortality Risk in Dementia Patients

A study finds dementia patients with significant weight loss face higher mortality risks, while stable weight or moderate gain lowers risks.

Unlocking Weight Loss: How GB102 Probiotics Enhance GLP-1 Obesity Drugs

GI Longevity's GB102 probiotic enhances weight loss with GLP-1 medications, reducing rebound gain and improving blood sugar control.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

Will South Korea’s Health Insurance Cover Youth Hair Loss Treatments?

South Korea's Ministry of Health reviews youth hair loss treatment for insurance coverage, emphasizing public debate and cost-effectiveness.

Eli Lilly’s New Weight Loss Pill Foundayo: A Game Changer in the GLP-1 Market?

The FDA has approved Eli Lilly's oral obesity drug Foundayo, enhancing competition in the weight loss market with flexible dosing.

New Study Reveals Radiation Dose Reduction May Cause Tumor Recurrence in Meningioma Patients

A study reveals that lower radiation doses for benign meningiomas near the optic nerve may lead to worse long-term outcomes and tumor regrowth.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

GLP-1 Weight Loss Injections: Are They Causing Gallstone Surge in Asia?

GLP-1 obesity treatments are linked to increased gallstone risk, especially during rapid weight loss, with cases doubling in South Korea.

Unlocking Weight Loss: Hanmi Pharmaceutical’s Innovative H.O.P Project and the Game-Changing Epaglenatide

Hanmi Pharmaceutical is innovating obesity treatment with efpeglenatide and HM15275, focusing on tailored solutions for Korean patients.

Is RPG-102 the Future of Obesity Treatment? Discover the Breakthrough Oral Solution!

ProGen and Rani Therapeutics initiate a Phase 1 trial for RPG-102, an oral obesity treatment, aiming for effective weight loss with weekly dosing.

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

K-pop Star HyunA Reveals the One Exercise That Changed Her Body

K-pop star HyunA shares her weight loss journey, emphasizing walking and diet while noting important exercise precautions.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.